We are live on
!
Find out more
IHM
Iguana Healthcare Management Portfolio holdings
AUM
$152M
1-Year Est. Return
48.74%
This Fund
S&P 500
This Quarter
Est. Return
+8.86%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$152M
AUM Growth
-$1.54M
(-1%)
Cap. Flow
+$1.94M
Cap. Flow
% of AUM
1.28%
Top 10 Holdings %
Top 10 Hldgs %
37.96%
Holding
86
New
25
Increased
15
Reduced
14
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZSAN
Zosano Pharma Corporation
ZSAN
|
+$4.78M |
| 2 |
SHPG
Shire pic
SHPG
|
+$3.44M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.29M |
| 4 |
Centene
CNC
|
+$3.13M |
| 5 |
Labcorp
LH
|
+$2.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$7.83M |
| 2 |
AERI
Aerie Pharmaceuticals
AERI
|
+$5.08M |
| 3 |
AbbVie
ABBV
|
+$4.84M |
| 4 |
ESPR
Esperion Therapeutics
ESPR
|
+$4.77M |
| 5 |
KTWO
K2M Group Holdings, Inc
KTWO
|
+$2.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 77.97% |
| 2 | Energy | 0% |
No holdings matched the selected filter criteria.
Similar funds
HWP
PAM
USG2
LCM
FPF
FIAS
CII
OPWM
Iguana Healthcare Management's Q1 2018 Portfolio in Review
As of Q1 2018, Iguana Healthcare Management held 86 positions worth $152M, down 1% from $154M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Iguana Healthcare Management's Q1 2018 filing shows 25 new, 15 increased, 14 reduced and 24 closed positions. Its largest new stake was Zosano Pharma Corporation: 14,286 shares worth $2.52M. The largest sale was Celgene Corp, an estimated $7.83M.
By sector, the portfolio is most concentrated in Healthcare at 78% of assets, down from 82% a quarter earlier, followed by Energy.
- Iguana Healthcare Management's largest Q1 2018 buy was Zosano Pharma Corporation: 14,286 shares worth $2.52M.
- Iguana Healthcare Management added most to Arena Pharmaceuticals Inc in Q1 2018, an estimated $1.94M increase.
- Iguana Healthcare Management's biggest Q1 2018 reduction was Esperion Therapeutics, cutting an estimated $4.77M.
- Iguana Healthcare Management fully exited Celgene Corp in Q1 2018, selling an estimated $7.83M.
- Iguana Healthcare Management's ten largest holdings make up 38% of its $152M portfolio in Q1 2018.
- Iguana Healthcare Management opened 25 new positions and closed 24 in Q1 2018.
- Iguana Healthcare Management's portfolio value fell 1% quarter-over-quarter to $152M.
Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.